Skip to main content
. 2022 Jan 11;23(3):434–439. doi: 10.1016/j.jamda.2021.12.001

Fig. 2.

Fig. 2

Neutralization capacity of the antibody response to SARS-CoV-2 vaccination. (A) Correlation between neutralization capacity and anti-Spike antibody titer (n = 24) (top left). (B) Neutralization capacity at baseline, 5 weeks, and 6 months post vaccination with a SARS-CoV-2 mRNA vaccine (top right). (C) Neutralization capacity over time in SARS-CoV-2–naïve participants. (D) Neutralization capacity over time in participants previously infected with SARS-CoV-2. Note: Neutralization values are presented as a percentage of a pool of 6 pre-pandemic controls, with greater. Note: Neutralization values are presented as a percentage of a pool of 6 pre-pandemic controls, with greater values indicating poorer neutralization capacity.